abstract |
This invention relates to novel, pharmaceutically active benzimidazolone derivatives of formula (I), wherein the dashed line, R0 through R6 and X1 through X3 are defined as in the specification. These compounds exhibit central dopaminergic activity and are useful in the treatment of CNS disorders. |